Name: Medical Tubing Market by Material (Plastics, Rubbers, Specialty Polymers), Application (Bulk Disposable Tubing, Catheters & Cannulas, Drug Delivery Systems), Structure (Single-Lumen, Multi-Lumen, Co-Extruded, Tapered or Bump, Braided) - Global Forecast to 2030
Brand: MarketsandMarkets
SKU: CH4564
Price: 4950 USD
Availability: InStock

報告摘要

The medical tubing market is projected to reach USD 18.41 billion by 2030 from USD 12.53 billion in 2025, at a CAGR of 8.0% during the forecast period. The expansion in the medical tubing market is due to rise in cases of chronic disease, including cardiovascular conditions, cancer, and respiratory conditions. Many of these illnesses demand medical equipment like catheters, infusion equipment, and ventilators that involve tubing for treatment and management effectiveness. For example, increasing prevalence of respiratory conditions such as asthma and tuberculosis has promoted demand for ventilator tubing systems. The rise in the elderly population, also more prone to chronic diseases and surgery, is another major reason. This increase in the old age population led to an uptrend in need for minimally invasive procedures with medical tubing featuring a key element in drug administration and fluid delivery systems. Moreover, companies' strategic moves, including product launches and mergers, are broadening market coverage and visibility. Finally, rigorous regulatory requirements and government spending on healthcare infrastructure are driving market growth by providing high-quality tubing products for various applications. All these factors together put the medical tubing market in line for long-term growth in the next few years. “Rubber is the second fastest-growing material in the medical tubing market during the forecast period.” Rubber is the second fastest-growing medical tubing material because of its better flexibility, durability, and biocompatibility, which make it suitable for numerous medical applications. Natural and synthetic rubbers, including silicone, latex, and thermoplastic elastomers (TPE), provide good resistance to harsh temperatures, chemicals, and multiple sterilization cycles. This makes rubber tubing ideally suited to be used in catheters, respiratory therapy units, peristaltic pumps, and surgery drainage systems. Silicone rubber is specifically used on a large scale owing to its superior biocompatibility, for which it is considered a material of choice for implantable and long-term medical uses. In addition, rubber products have higher resilience that allows medical tubing to withstand bending and stretching without loss of integrity, hence offering enhanced patient comfort and device performance. The growing prevalence of chronic conditions, such as cardiovascular and respiratory diseases, has fueled the demand for medical devices that incorporate rubber tubing. In addition, advances in rubber formulations, including antimicrobial coatings and increased tensile strength, have contributed to its applications in critical care. With advances in healthcare innovation, rubber tubing continues to be a top contender, thus qualifying it as the second fastest-growing material in the medical tubing market. “Braided tubing is the second fastest-growing structure in the medical tubing market during the forecast period.” Braided tubing is the second fastest-growing medical tubing structure because of its excellent combination of strength, flexibility, and versatility that can address a broad spectrum of sophisticated medical uses. Its structure, with a reinforcing braided layer commonly composed of materials such as stainless steel or nylon inserted inside polymer tubing, provides the best resistance to high pressure and kinking than its non-reinforced counterparts. This makes it most appropriate for high-performance applications such as catheters, endoscopes, and cardiovascular devices, where durability and precise fluid delivery are of the highest priority. The growing need for minimally invasive procedures, which require tubing that can navigate through intricate anatomical pathways without compromising performance, significantly enhances its application. Braided tubing can withstand sterilization processes and maintain structural integrity under stress conditions also helps in meeting the strict safety requirements of the medical sector. Rising prevalence of chronic diseases, coupled with the aging population and their requirement for advanced diagnostic and therapeutic equipment, also fuels its market growth. New braiding technology and material science enable it to be even more flexible and enable customization to fulfill particular medical needs. While single-lumen tubing may be the culprit by way of simplicity and ubiquity, the greater mechanical properties and biocompatibility of braided tubing with high-performance uses position it as a fast-rising market that responds well to shifting needs of modern healthcare. “Catheters & cannulas is the second fastest-growing structure in the medical tubing market during the forecast period.” The catheters & cannulas market is the second fastest-growing application of the medical tubing market owing to a number of major driving factors behind its demand. As the global healthcare systems focus on minimally invasive interventions, catheters & cannulas are becoming the tools of choice, providing safer and less traumatic alternatives to conventional surgeries. These soft tubes play a vital role in uses such as cardiovascular interventions, urinary drainage, and intravenous therapy, where accuracy and patient comfort are of utmost importance. Growing prevalence of chronic illness, including cardiovascular conditions, diabetes, and renal disorders, mainly in aging communities, also catalyzes such expansion. Demand for catheterization in treatment of heart problems or urinary incontinence automatically increases demand for special tubing. Advancements in technology also are contributing factors with improved biocompatible materials, including silicone and polyurethane, improving functionality, longevity, and safety for catheters & cannulas. Besides, the move towards outpatient treatment and home healthcare increases their application in portable equipment, like infusion pumps. The segment is helped by the increasing investments in healthcare, particularly in sectors that are emerging, as enhanced infrastructure and availability of medical services increase the demand for disposable and sterile tubing. “The Middle East and Africa (MEA) market is projected to register the second fastest growing market for medical tubing during the forecast period.” Middle East & Africa (MEA) is the second fastest-growing market for medical tubing owing to mounting healthcare investment, enhancing medical infrastructure, and rising demand for high-tech medical devices. Regional governments, specifically those of Saudi Arabia, UAE, and South Africa, are greatly investing in the modernization of healthcare, generating the demand for superior medical tubing for usage in hospitals, clinics, and diagnostic centers. The growth of healthcare facilities, coupled with the creation of medical free zones and manufacturing centers, is increasing local production and distribution of medical tubing and associated devices. The increasing incidence of chronic diseases like diabetes, cardiovascular diseases, and respiratory diseases has boosted the use of medical tubing in drug delivery systems, catheters, and respiratory devices. The increased geriatric population in the region also demands advanced medical treatment, thereby propelling the use of medical tubing-based applications. The transition towards home healthcare and wearable medical devices, including insulin pumps and oxygen therapy devices, is another key driver for market growth. Worldwide medical device companies are expanding their reach in the MEA region through collaborations, joint ventures, and establishing regional production units. All this growth increases the number of better-quality medical tubing products available and reduces dependency on imports, and consequently healthcare becomes affordable. Medical tubing technologies such as biodegradable and antimicrobial medical tubing grow more popular in MEA as healthcare professionals continue to prioritize infection control and eco-friendliness. Extensive primary interviews were conducted to determine and verify the market size for several segments and sub-segments and the information gathered through secondary research. The break-up of primary interviews is given below: • By Department: Tier 1: 40%, Tier 2: 25%, and Tier 3: 35% • By Designation: C Level: 35%, Director Level: 30%, and Executives: 35% • By Region: North America: 25%, Europe: 45%, Asia Pacific: 20%, South America: 5%, Middle East & Africa 5% Saint-Gobain (France), Freudenberg Medical (US), W. L. Gore & Associates, Inc. (US), The Lubrizol Corporation (US), Nordson Corporation (US), TE Connectivity (Switzerland), Elkem ASA (Norway), Trelleborg AB (Sweden), RAUMEDIC AG (Germany), Teknor Apex (US), Spectrum Plastics Group (US) Zeus Company LLC (US) among others are some of the key players in the medical tubing market. The study includes an in-depth competitive analysis of these key players in the authentication and brand protection market, with their company profiles, recent developments, and key market strategies. Research Coverage The market study covers the medical tubing market across various segments. It aims to estimate the market size and the growth potential of this market across different segments based on material, application, structure, end-use industry, and region. The study also includes an in-depth competitive analysis of key players in the market, their company profiles, key observations related to their products and business offerings, recent developments undertaken by them, and key growth strategies adopted by them to improve their position in the medical tubing market. Key Benefits of Buying the Report The report is expected to help the market leaders/new entrants in this market share the closest approximations of the revenue numbers of the overall medical tubing market and its segments and sub-segments. This report is projected to help stakeholders understand the competitive landscape of the market, gain insights to improve the position of their businesses, and plan suitable go-to-market strategies. The report also aims to help stakeholders understand the pulse of the market and provides them with information on the key market drivers, restraints, challenges, and opportunities. The report provides insights on the following pointers: • Analysis of key drivers (Increase in geriatric population, Increasing demand for minimally invasive medical procedures, Stringent quality standards and regulations, Advancements in extrusion technology), restraints (Limited material compatibility), opportunities (Customization and innovation in polymers and tubing structure, Increasing government expenditure for upgrading and developing healthcare infrastructure), challenges (High cost of producing and marketing medical tubing products). • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the medical tubing market • Market Development: Comprehensive information about lucrative markets – the report analyses the medical tubing market across varied regions • Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the medical tubing market • Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players like Saint-Gobain (France), Freudenberg Medical (US), W. L. Gore & Associates, Inc. (US), The Lubrizol Corporation (US), Nordson Corporation (US), TE Connectivity (Switzerland), Elkem ASA (Norway), Trelleborg AB (Sweden), RAUMEDIC AG (Germany), Teknor Apex (US), Spectrum Plastics Group (US) Zeus Company LLC (US) among others are the top manufacturers covered in the medical tubing market.

目錄 Table of Contents

1 INTRODUCTION 25 1.1 STUDY OBJECTIVES 25 1.2 MARKET DEFINITION 25 1.3 STUDY SCOPE 26 1.3.1 MARKETS COVERED AND REGIONAL SCOPE 26 1.3.2 INCLUSIONS AND EXCLUSIONS 26 1.3.3 YEARS CONSIDERED 27 1.3.4 CURRENCY CONSIDERED 27 1.3.5 UNITS CONSIDERED 27 1.4 STAKEHOLDERS 27 1.5 SUMMARY OF CHANGES 28 2 RESEARCH METHODOLOGY 29 2.1 RESEARCH DATA 29 2.1.1 SECONDARY DATA 30 2.1.1.1 List of key secondary sources 30 2.1.1.2 Key data from secondary sources 30 2.1.2 PRIMARY DATA 31 2.1.2.1 Key data from primary sources 31 2.1.2.2 List of primary interview participants—demand and supply side 31 2.1.2.3 Key industry insights 32 2.1.2.4 Breakdown of interviews with experts 32 2.2 MARKET SIZE ESTIMATION 32 2.2.1 BOTTOM-UP APPROACH 33 2.2.2 TOP-DOWN APPROACH 33 2.3 FORECAST NUMBER CALCULATION 34 2.4 DATA TRIANGULATION 34 2.5 FACTOR ANALYSIS 35 2.6 ASSUMPTIONS 36 2.7 LIMITATIONS AND RISKS 36 3 EXECUTIVE SUMMARY 37 4 PREMIUM INSIGHTS 40 4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN MEDICAL TUBING MARKET 40 4.2 MEDICAL TUBING MARKET, BY MATERIAL 40 4.3 MEDICAL TUBING MARKET, BY APPLICATION 41 4.4 MEDICAL TUBING MARKET, BY REGION 41 5 MARKET OVERVIEW 42 5.1 INTRODUCTION 42 5.2 MARKET DYNAMICS 42 5.2.1 DRIVERS 43 5.2.1.1 Growing geriatric population 43 5.2.1.2 Increasing demand for minimally invasive medical procedures 44 5.2.1.3 Advancements in extrusion technology 45 5.2.1.4 Stringent quality standards and regulations 45 5.2.2 RESTRAINTS 46 5.2.2.1 Limited material compatibility 46 5.2.2.2 Environmental and disposal concerns 47 5.2.3 OPPORTUNITIES 47 5.2.3.1 Advancements in biocompatible and smart materials 47 5.2.3.2 Increasing government expenditure to upgrade and develop healthcare infrastructure 48 5.2.4 CHALLENGES 50 5.2.4.1 High production costs and marketing complexities 50 5.3 PORTER’S FIVE FORCES ANALYSIS 51 5.3.1 THREAT OF NEW ENTRANTS 52 5.3.2 THREAT OF SUBSTITUTES 52 5.3.3 BARGAINING POWER OF SUPPLIERS 52 5.3.4 BARGAINING POWER OF BUYERS 52 5.3.5 INTENSITY OF COMPETITIVE RIVALRY 53 5.4 KEY STAKEHOLDERS AND BUYING CRITERIA 53 5.4.1 KEY STAKEHOLDERS IN BUYING PROCESS 53 5.4.2 BUYING CRITERIA 54 5.5 MACROECONOMIC INDICATORS 54 5.5.1 GLOBAL GDP TRENDS 54 6 INDUSTRY TRENDS 58 6.1 INTRODUCTION 58 6.2 VALUE CHAIN ANALYSIS 58 6.3 REGULATORY LANDSCAPE 59 6.3.1 REGULATIONS 59 6.3.1.1 North America 60 6.3.1.2 Asia Pacific 60 6.3.1.3 Europe 60 6.3.2 STANDARDS 61 6.3.2.1 ISO standard 61 6.3.2.2 Food and drug administration (FDA) 61 6.3.2.3 ASTM (American society for testing and materials) standards 61 6.3.3 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 62 6.4 TRADE ANALYSIS 64 6.4.1 IMPORT SCENARIO (HS CODE 3917) 64 6.4.2 EXPORT SCENARIO (HS CODE 3917) 65 6.5 ECOSYSTEM ANALYSIS 66 6.6 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 67 6.7 CASE STUDY ANALYSIS 68 6.7.1 FREUDENBERG MEDICAL TO PROVIDE SPECIALTY BALLOON CATHETERS 68 6.7.2 W. L. GORE & ASSOCIATES, INC. PROVIDES GORE STA-PURE PUMP TUBING 69 6.8 TECHNOLOGY ANALYSIS 69 6.8.1 KEY TECHNOLOGIES 69 6.8.1.1 Extrusion technology 69 6.8.1.2 Advanced material technologies 70 6.8.2 COMPLEMENTARY TECHNOLOGIES 70 6.8.2.1 Smart technologies and connectivity 70 6.8.2.2 Surface treatment and modification 71 6.9 KEY CONFERENCES AND EVENTS, 2025 71 6.10 PATENT ANALYSIS 72 6.10.1 METHODOLOGY 72 6.10.2 DOCUMENT TYPES 72 6.10.3 PUBLICATION TRENDS IN LAST 11 YEARS 73 6.10.4 INSIGHTS 73 6.10.5 LEGAL STATUS OF PATENTS 73 6.10.6 JURISDICTION ANALYSIS 74 6.10.7 TOP APPLICANTS 75 6.11 IMPACT OF AI/GEN AI ON MEDICAL TUBING MARKET 76 6.12 PRICING ANALYSIS 76 6.12.1 AVERAGE SELLING PRICE, BY REGION, 2021–2024 76 6.12.2 AVERAGE SELLING PRICE FOR TOP THREE APPLICATIONS, BY KEY PLAYER, 2024 77 6.12.3 AVERAGE SELLING PRICE TREND, BY MATERIAL, 2021–2024 77 6.13 INVESTMENT AND FUNDING SCENARIO 78 7 MEDICAL TUBING MARKET, BY APPLICATION 79 7.1 INTRODUCTION 80 7.2 BULK DISPOSABLE TUBING 81 7.2.1 DEMAND FROM HOSPITALS, HOME HEALTHCARE PROVIDERS, AND EMERGENCY CARE PROVIDERS TO BOOST MARKET 81 7.2.2 DIALYSIS TUBING 82 7.2.2.1 Growing aging population to drive demand 82 7.2.3 INTRAVENOUS TUBING 82 7.2.3.1 Technological advancements to drive market 82 7.3 CATHETERS & CANNULAS 82 7.3.1 RISING CARDIOVASCULAR DISEASES AND DEMAND FOR MINIMALLY INVASIVE SURGICAL PROCEDURES TO FUEL MARKET GROWTH 82 7.3.2 CATHETERS 83 7.3.2.1 Increase in chronic diseases contributing to significant demand 83 7.3.2.2 Cardiovascular catheters 83 7.3.2.2.1 Growing elderly population and high incidence of cardiovascular diseases to propel market 83 7.3.2.3 IV catheters 83 7.3.2.3.1 Demand for direct delivery of medication and nutrients into bloodstream to fuel growth 83 7.3.2.4 Urinary catheters 84 7.3.2.4.1 Rising incidences of urinary tract infections and growing need for advanced technologies to drive demand 84 7.3.3 CANNULAS 84 7.3.3.1 Evolving healthcare sector and stringent regulatory requirements to support market growth 84 7.4 DRUG DELIVERY SYSTEMS 85 7.4.1 PRECISE DRUG DELIVERY TO TARGET SITES TO DRIVE DEMAND 85 7.4.2 NASOGASTRIC 85 7.4.2.1 Need for enteral feeding and drainage to fuel demand 85 7.4.3 NEBULIZERS 85 7.4.3.1 Conversion of liquid medications to mists for inhalation to drive market 85 7.5 OTHER APPLICATIONS 86 7.5.1 PERISTALTIC PUMP TUBING 86 7.5.1.1 Wide demand for minimizing contamination to boost market 86 7.5.2 GAS SUPPLY TUBING 86 7.5.2.1 Increasing minimally invasive surgeries to support market growth 86 7.5.3 SMOKE EVACUATION TUBING 86 7.5.3.1 Popularity of cosmetic procedures and medical tourism to drive market 86 8 MEDICAL TUBING MARKET, BY MATERIAL 87 8.1 INTRODUCTION 88 8.2 PLASTICS 89 8.2.1 BIOCOMPATIBILITY, CHEMICAL STABILITY, AND COST-EFFECTIVENESS TO BOOST MARKET 89 8.2.2 POLYVINYL CHLORIDE (PVC) 89 8.2.3 POLYOLEFIN 90 8.2.3.1 Polyethylene (PE) 90 8.2.3.2 Polypropylene (PP) 90 8.2.4 POLYAMIDE 91 8.2.5 POLYTETRAFLUOROETHYLENE (PTFE) 91 8.2.6 POLYETHER ETHER KETONE (PEEK) 91 8.2.7 POLYCARBONATE (PC) 92 8.3 RUBBERS 92 8.3.1 SIGNIFICANT DURABILITY AND RESILIENCE TO DRIVE DEMAND 92 8.3.2 THERMOPLASTIC ELASTOMER (TPE) 92 8.3.3 THERMOPLASTIC POLYURETHANE (TPU) 92 8.3.4 SILICONE 93 8.3.5 POLYURETHANE (PU) 93 8.3.6 ETHYLENE PROPYLENE DIENE MONOMER (EPDM) 93 8.3.7 LATEX 93 8.4 SPECIALTY POLYMERS 94 8.4.1 DEMAND FOR SPECIALIZED TREATMENT TO BOOST MARKET 94 8.4.2 BIOABSORBABLE POLYMERS 94 8.4.3 ETHYLENE VINYL ACETATE (EVA) 94 8.5 OTHER MATERIALS 94 9 MEDICAL TUBING MARKET, BY STRUCTURE 95 9.1 INTRODUCTION 96 9.2 SINGLE-LUMEN 98 9.2.1 DEMAND FOR ADMINISTRATION OF FLUIDS AND MEDICATION, AIRWAY MANAGEMENT, AND PATIENT NUTRITION TO DRIVE MARKET 98 9.3 CO-EXTRUDED 98 9.3.1 DURABILITY, LUBRICITY, OPACITY, RADIOPACITY, AND TENSILE STRENGTH TO BOOST MARKET 98 9.4 MULTI-LUMEN 99 9.4.1 NON-TOXICITY, BIOCOMPATIBILITY, AND INERTNESS TO FUEL MARKET DEMAND 99 9.5 TAPERED OR BUMP TUBING 99 9.5.1 ENHANCED FUNCTIONALITIES IN CVC, PICC, AND DRUG DELIVERY CATHETERS TO DRIVE MARKET 99 9.6 BRAIDED TUBING 100 9.6.1 GOOD STRENGTH, STEERABILITY, AND PRESSURE RESISTANCE TO PROPEL MARKET 100 10 MEDICAL TUBING MARKET, BY REGION 101 10.1 INTRODUCTION 102 10.2 NORTH AMERICA 103 10.2.1 US 107 10.2.1.1 High disposable income and strong healthcare infrastructure to drive market 107 10.2.2 CANADA 108 10.2.2.1 Aging population and increasing healthcare expenditure to support market growth 108 10.2.3 MEXICO 110 10.2.3.1 High investments and low manufacturing costs to fuel demand 110 10.3 EUROPE 112 10.3.1 GERMANY 115 10.3.1.1 Advanced medical facilities and R&D investments to propel market 115 10.3.2 FRANCE 117 10.3.2.1 Rising elderly population to fuel market growth 117 10.3.3 UK 118 10.3.3.1 Innovation, technological advancements, and investments to drive market 118 10.3.4 SPAIN 120 10.3.4.1 Growing aging population and improvements in healthcare system to increase consumption 120 10.3.5 ITALY 121 10.3.5.1 Growing geriatric population and strong focus on research and innovation to drive market 121 10.3.6 NETHERLANDS 123 10.3.6.1 Rising homecare treatment to increase demand 123 10.3.7 REST OF EUROPE 124 10.4 ASIA PACIFIC 126 10.4.1 CHINA 130 10.4.1.1 Investments in manufacturing medical devices to support market 130 10.4.2 JAPAN 131 10.4.2.1 Implementation of AI and big data technologies in healthcare industry to increase demand 131 10.4.3 INDIA 133 10.4.3.1 Government initiatives, high purchasing power, and rising manufacturing output to fuel demand 133 10.4.4 SOUTH KOREA 135 10.4.4.1 Medical tourism to lead to market growth 135 10.4.5 REST OF ASIA PACIFIC 136 10.5 MIDDLE EAST & AFRICA 138 10.5.1 GCC COUNTRIES 141 10.5.1.1 Saudi Arabia 141 10.5.1.1.1 Government initiatives to support market growth 141 10.5.1.2 UAE 143 10.5.1.2.1 Government funding and rapidly developing private health sector to drive market 143 10.5.2 SOUTH AFRICA 144 10.5.2.1 Increasing awareness, testing, and treatment programs to drive market 144 10.5.3 EGYPT 146 10.5.3.1 Technological advancements and improving healthcare sector to fuel demand 146 10.5.4 REST OF MIDDLE EAST & AFRICA 147 10.6 SOUTH AMERICA 149 10.6.1 BRAZIL 151 10.6.1.1 Growing healthcare system to increase consumption 151 10.6.2 ARGENTINA 152 10.6.2.1 Rising prevalence of chronic diseases, aging population, and advances in medical sector to drive market 152 10.6.3 REST OF SOUTH AMERICA 154 11 COMPETITIVE LANDSCAPE 156 11.1 OVERVIEW 156 11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2020–2025 156 11.3 REVENUE ANALYSIS, 2024 159 11.4 MARKET SHARE ANALYSIS, 2024 160 11.4.1 SAINT-GOBAIN 161 11.4.2 FREUDENBERG MEDICAL 161 11.4.3 THE LUBRIZOL CORPORATION 162 11.4.4 W. L. GORE & ASSOCIATES, INC. 162 11.4.5 TE CONNECTIVITY 162 11.5 COMPANY VALUATION AND FINANCIAL METRICS 162 11.6 BRAND COMPARISON 164 11.6.1 MEDICAL TUBING MARKET: BRAND COMPARISON 164 11.6.2 BIO-SIL TUBING 164 11.6.3 HELIXFLEX 165 11.6.4 ISOPLAST ETPU MEDICAL TUBING 165 11.6.5 GORE STA-PURE PUMP TUBING SERIES PFL 165 11.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 165 11.7.1 STARS 165 11.7.2 EMERGING LEADERS 165 11.7.3 PERVASIVE PLAYERS 166 11.7.4 PARTICIPANTS 166 11.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 167 11.7.5.1 Company footprint 167 11.7.5.2 Region footprint 168 11.7.5.3 Structure footprint 169 11.7.5.4 Material footprint 170 11.7.5.5 Application footprint 171 11.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023 172 11.8.1 PROGRESSIVE COMPANIES 172 11.8.2 RESPONSIVE COMPANIES 172 11.8.3 DYNAMIC COMPANIES 172 11.8.4 STARTING BLOCKS 172 11.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023 174 11.8.5.1 Detailed list of key startups/SMEs 174 11.8.5.2 Competitive benchmarking of startups/SMEs 175 11.9 COMPETITIVE SCENARIO 176 11.9.1 PRODUCT LAUNCHES 176 11.9.2 DEALS 178 11.9.3 OTHER DEVELOPMENTS 180 12 COMPANY PROFILES 182 12.1 KEY PLAYERS 182 12.1.1 SAINT-GOBAIN 182 12.1.1.1 Business overview 182 12.1.1.2 Products/Solutions/Services offered 183 12.1.1.3 Recent developments 186 12.1.1.3.1 Deals 186 12.1.1.4 MnM view 186 12.1.1.4.1 Right to win 186 12.1.1.4.2 Strategic choices 186 12.1.1.4.3 Weaknesses and competitive threats 186 12.1.2 FREUDENBERG MEDICAL 187 12.1.2.1 Business overview 187 12.1.2.2 Products/Solutions/Services offered 188 12.1.2.3 Recent developments 192 12.1.2.3.1 Product launches 192 12.1.2.3.2 Deals 192 12.1.2.3.3 Expansions 193 12.1.2.4 MnM view 194 12.1.2.4.1 Right to win 194 12.1.2.4.2 Strategic choices 194 12.1.2.4.3 Weaknesses and competitive threats 194 12.1.3 THE LUBRIZOL CORPORATION 195 12.1.3.1 Business overview 195 12.1.3.2 Products/Solutions/Services offered 196 12.1.3.3 Recent developments 198 12.1.3.3.1 Deals 198 12.1.3.3.2 Expansions 198 12.1.3.4 MnM view 199 12.1.3.4.1 Right to win 199 12.1.3.4.2 Strategic choices 199 12.1.3.4.3 Weaknesses and competitive threats 199 12.1.4 W. L. GORE & ASSOCIATES, INC. 200 12.1.4.1 Business overview 200 12.1.4.2 Products/Solutions/Services offered 200 12.1.4.3 MnM view 201 12.1.4.3.1 Right to win 201 12.1.4.3.2 Strategic choices 201 12.1.4.3.3 Weaknesses and competitive threats 201 12.1.5 NORDSON CORPORATION 202 12.1.5.1 Business overview 202 12.1.5.2 Products/Solutions/Services offered 203 12.1.5.3 Recent developments 205 12.1.5.3.1 Deals 205 12.1.5.4 MnM view 206 12.1.5.4.1 Right to win 206 12.1.5.4.2 Strategic choices 206 12.1.5.4.3 Weaknesses and competitive threats 206 12.1.6 TE CONNECTIVITY 207 12.1.6.1 Business overview 207 12.1.6.2 Products/Solutions/Services offered 208 12.1.6.3 Recent developments 209 12.1.6.3.1 Product launches 209 12.1.6.4 MnM view 209 12.1.7 ELKEM ASA 210 12.1.7.1 Business overview 210 12.1.7.2 Products/Solutions/Services offered 211 12.1.7.3 Recent developments 212 12.1.7.3.1 Deals 212 12.1.7.3.2 Expansions 212 12.1.7.4 MnM view 212 12.1.8 TRELLEBORG AB 213 12.1.8.1 Business overview 213 12.1.8.2 Products/Solutions/Services offered 214 12.1.8.3 Recent developments 216 12.1.8.3.1 Deals 216 12.1.8.3.2 Other developments 216 12.1.8.4 MnM view 216 12.1.9 RAUMEDIC AG 217 12.1.9.1 Business overview 217 12.1.9.2 Products/Solutions/Services offered 217 12.1.9.3 Recent developments 219 12.1.9.3.1 Product launches 219 12.1.9.3.2 Deals 219 12.1.9.3.3 Expansions 220 12.1.9.4 MnM view 220 12.1.10 TEKNOR APEX 221 12.1.10.1 Business overview 221 12.1.10.2 Products/Solutions/Services offered 221 12.1.10.3 Recent developments 222 12.1.10.3.1 Product launches 222 12.1.10.3.2 Deals 222 12.1.10.4 MnM view 223 12.1.11 SPECTRUM PLASTICS GROUP 224 12.1.11.1 Business overview 224 12.1.11.2 Products/Solutions/Services offered 224 12.1.11.3 Recent developments 226 12.1.11.3.1 Deals 226 12.1.11.3.2 Expansions 226 12.1.11.4 MnM view 227 12.1.12 ZEUS COMPANY LLC 228 12.1.12.1 Business overview 228 12.1.12.2 Products/Solutions/Services offered 228 12.1.12.3 Recent developments 230 12.1.12.3.1 Product launches 230 12.1.12.3.2 Expansions 230 12.1.12.4 MnM view 230 12.2 OTHER PLAYERS 231 12.2.1 ATAG SPA 231 12.2.2 DAVIS STANDARD 232 12.2.3 FBK MEDICAL TUBING 233 12.2.4 PROTERIAL CABLE AMERICA, INC. 234 12.2.5 ICO RALLY 235 12.2.6 ICU MEDICAL, INC. 236 12.2.7 KRATON CORPORATION 237 12.2.8 MICROLUMEN INC. 238 12.2.9 MDC INDUSTRIES 239 12.2.10 NEWAGE INDUSTRIES 240 12.2.11 OPTINOVA 241 12.2.12 PARKER HANNIFIN CORP. 242 12.2.13 TEEL PLASTICS 243 12.2.14 VESTA INC. 244 12.2.15 SMOOTH-BOR PLASTICS 245 13 APPENDIX 246 13.1 DISCUSSION GUIDE 246 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 249 13.3 CUSTOMIZATION OPTIONS 251 13.4 RELATED REPORTS 251 13.5 AUTHOR DETAILS 252

圖表清單 List of Tables & Figures

TABLE 1 LIST OF KEY SECONDARY SOURCES 30 TABLE 2 SHARE OF POPULATION ABOVE 65 YEARS OF AGE, BY COUNTRY, 2020 43 TABLE 3 LIST OF STANDARDS AND REGULATIONS FOR MEDICAL TUBING 46 TABLE 4 CAPITAL HEALTHCARE EXPENDITURE, 2020–2023 (USD MILLION) 49 TABLE 5 HEALTHCARE SPENDING, 2023 (USD MILLION) 49 TABLE 6 MEDICAL TUBING MARKET: PORTER’S FIVE FORCES ANALYSIS 51 TABLE 7 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE APPLICATIONS (%) 53 TABLE 8 KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS 54 TABLE 9 TRENDS OF PER CAPITA GDP, BY KEY COUNTRY, 2020–2023 (USD) 55 TABLE 10 GDP GROWTH ESTIMATE AND PROJECTION, BY KEY COUNTRY, 2024–2027 (USD) 55 TABLE 11 HEALTH EXPENDITURE AS PERCENTAGE OF GDP, BY KEY COUNTRY, 2019–2022 56 TABLE 12 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 62 TABLE 13 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 62 TABLE 14 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 63 TABLE 15 IMPORT SCENARIO FOR HS CODE 3917-COMPLIANT PRODUCTS, BY COUNTRY, 2020–2024 (USD MILLION) 65 TABLE 16 EXPORT SCENARIO FOR HS CODE 3917-COMPLIANT PRODUCTS, BY COUNTRY, 2020–2024 (USD MILLION) 66 TABLE 17 ROLE OF COMPANIES IN MEDICAL TUBING ECOSYSTEM 67 TABLE 18 MEDICAL TUBING MARKET: LIST OF KEY CONFERENCES AND EVENTS, 2025 71 TABLE 19 TOP 10 PATENT OWNERS DURING LAST ELEVEN YEARS, 2015–2024 75 TABLE 20 MEDICAL TUBING MARKET, BY APPLICATION, 2021–2024 (KILOTON) 80 TABLE 21 MEDICAL TUBING MARKET, BY APPLICATION, 2025–2030 (KILOTON) 81 TABLE 22 MEDICAL TUBING MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 81 TABLE 23 MEDICAL TUBING MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 81 TABLE 24 MEDICAL TUBING MARKET, BY MATERIAL, 2021–2024 (KILOTON) 88 TABLE 25 MEDICAL TUBING MARKET, BY MATERIAL, 2025–2030 (KILOTON) 88 TABLE 26 MEDICAL TUBING MARKET, BY MATERIAL, 2021–2024 (USD MILLION) 89 TABLE 27 MEDICAL TUBING MARKET, BY MATERIAL, 2025–2030 (USD MILLION) 89 TABLE 28 MEDICAL TUBING MARKET, BY STRUCTURE, 2021–2024 (KILOTON) 96 TABLE 29 MEDICAL TUBING MARKET, BY STRUCTURE, 2025–2030 (KILOTON) 97 TABLE 30 MEDICAL TUBING MARKET, BY STRUCTURE, 2021–2024 (USD MILLION) 97 TABLE 31 MEDICAL TUBING MARKET, BY STRUCTURE, 2025–2030 (USD MILLION) 97 TABLE 32 MEDICAL TUBING MARKET, BY REGION, 2021–2024 (KILOTON) 102 TABLE 33 MEDICAL TUBING MARKET, BY REGION, 2025–2030 (KILOTON) 103 TABLE 34 MEDICAL TUBING MARKET, BY REGION, 2021–2024 (USD MILLION) 103 TABLE 35 MEDICAL TUBING MARKET, BY REGION, 2025–2030 (USD MILLION) 103 TABLE 36 NORTH AMERICA: MEDICAL TUBING MARKET, BY COUNTRY, 2021–2024 (KILOTON) 105 TABLE 37 NORTH AMERICA: MEDICAL TUBING MARKET, BY COUNTRY, 2025–2030 (KILOTON) 105 TABLE 38 NORTH AMERICA: MEDICAL TUBING MARKET, BY COUNTRY, 2021–2024 (USD MILLION) 105 TABLE 39 NORTH AMERICA: MEDICAL TUBING MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 105 TABLE 40 NORTH AMERICA: MEDICAL TUBING MARKET, BY APPLICATION, 2021–2024 (KILOTON) 106 TABLE 41 NORTH AMERICA: MEDICAL TUBING MARKET, BY APPLICATION, 2025–2030 (KILOTON) 106 TABLE 42 NORTH AMERICA: MEDICAL TUBING MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 106 TABLE 43 NORTH AMERICA: MEDICAL TUBING MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 106 TABLE 44 US: MEDICAL TUBING MARKET, BY APPLICATION, 2021–2024 (KILOTON) 107 TABLE 45 US: MEDICAL TUBING MARKET, BY APPLICATION, 2025–2030 (KILOTON) 108 TABLE 46 US: MEDICAL TUBING MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 108 TABLE 47 US: MEDICAL TUBING MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 108 TABLE 48 CANADA: MEDICAL TUBING MARKET, BY APPLICATION, 2021–2024 (KILOTON) 109 TABLE 49 CANADA: MEDICAL TUBING MARKET, BY APPLICATION, 2025–2030 (KILOTON) 109 TABLE 50 CANADA: MEDICAL TUBING MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 110 TABLE 51 CANADA: MEDICAL TUBING MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 110 TABLE 52 MEXICO: MEDICAL TUBING MARKET, BY APPLICATION, 2021–2024 (KILOTON) 111 TABLE 53 MEXICO: MEDICAL TUBING MARKET, BY APPLICATION, 2025–2030 (KILOTON) 111 TABLE 54 MEXICO: MEDICAL TUBING MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 111 TABLE 55 MEXICO: MEDICAL TUBING MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 111 TABLE 56 EUROPE: MEDICAL TUBING MARKET, BY COUNTRY, 2021–2024 (KILOTON) 113 TABLE 57 EUROPE: MEDICAL TUBING MARKET, BY COUNTRY, 2025–2030 (KILOTON) 113 TABLE 58 EUROPE: MEDICAL TUBING MARKET, BY COUNTRY, 2021–2024 (USD MILLION) 113 TABLE 59 EUROPE: MEDICAL TUBING MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 114 TABLE 60 EUROPE: MEDICAL TUBING MARKET, BY APPLICATION, 2021–2024 (KILOTON) 114 TABLE 61 EUROPE: MEDICAL TUBING MARKET, BY APPLICATION, 2025–2030 (KILOTON) 114 TABLE 62 EUROPE: MEDICAL TUBING MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 115 TABLE 63 EUROPE: MEDICAL TUBING MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 115 TABLE 64 GERMANY: MEDICAL TUBING MARKET, BY APPLICATION, 2021–2024 (KILOTON) 116 TABLE 65 GERMANY: MEDICAL TUBING MARKET, BY APPLICATION, 2025–2030 (KILOTON) 116 TABLE 66 GERMANY: MEDICAL TUBING MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 116 TABLE 67 GERMANY: MEDICAL TUBING MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 116 TABLE 68 FRANCE: MEDICAL TUBING MARKET, BY APPLICATION, 2021–2024 (KILOTON) 117 TABLE 69 FRANCE: MEDICAL TUBING MARKET, BY APPLICATION, 2025–2030 (KILOTON) 117 TABLE 70 FRANCE: MEDICAL TUBING MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 118 TABLE 71 FRANCE: MEDICAL TUBING MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 118 TABLE 72 UK: MEDICAL TUBING MARKET, BY APPLICATION, 2021–2024 (KILOTON) 119 TABLE 73 UK: MEDICAL TUBING MARKET, BY APPLICATION, 2025–2030 (KILOTON) 119 TABLE 74 UK: MEDICAL TUBING MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 119 TABLE 75 UK: MEDICAL TUBING MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 119 TABLE 76 SPAIN: MEDICAL TUBING MARKET, BY APPLICATION, 2021–2024 (KILOTON) 120 TABLE 77 SPAIN: MEDICAL TUBING MARKET, BY APPLICATION, 2025–2030 (KILOTON) 120 TABLE 78 SPAIN: MEDICAL TUBING MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 121 TABLE 79 SPAIN: MEDICAL TUBING MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 121 TABLE 80 ITALY: MEDICAL TUBING MARKET, BY APPLICATION, 2021–2024 (KILOTON) 122 TABLE 81 ITALY: MEDICAL TUBING MARKET, BY APPLICATION, 2025–2030 (KILOTON) 122 TABLE 82 ITALY: MEDICAL TUBING MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 122 TABLE 83 ITALY: MEDICAL TUBING MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 123 TABLE 84 NETHERLANDS: MEDICAL TUBING MARKET, BY APPLICATION, 2021–2024 (KILOTON) 123 TABLE 85 NETHERLANDS: MEDICAL TUBING MARKET, BY APPLICATION, 2025–2030 (KILOTON) 124 TABLE 86 NETHERLANDS: MEDICAL TUBING MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 124 TABLE 87 NETHERLANDS: MEDICAL TUBING MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 124 TABLE 88 REST OF EUROPE: MEDICAL TUBING MARKET, BY APPLICATION, 2021–2024 (KILOTON) 125 TABLE 89 REST OF EUROPE: MEDICAL TUBING MARKET, BY APPLICATION, 2025–2030 (KILOTON) 125 TABLE 90 REST OF EUROPE: MEDICAL TUBING MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 125 TABLE 91 REST OF EUROPE: MEDICAL TUBING MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 125 TABLE 92 ASIA PACIFIC: MEDICAL TUBING MARKET, BY COUNTRY, 2021–2024 (KILOTON) 127 TABLE 93 ASIA PACIFIC: MEDICAL TUBING MARKET, BY COUNTRY, 2025–2030 (KILOTON) 128 TABLE 94 ASIA PACIFIC: MEDICAL TUBING MARKET, BY COUNTRY, 2021–2024 (USD MILLION) 128 TABLE 95 ASIA PACIFIC: MEDICAL TUBING MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 128 TABLE 96 ASIA PACIFIC: MEDICAL TUBING MARKET, BY APPLICATION, 2021–2024 (KILOTON) 128 TABLE 97 ASIA PACIFIC: MEDICAL TUBING MARKET, BY APPLICATION, 2025–2030 (KILOTON) 129 TABLE 98 ASIA PACIFIC: MEDICAL TUBING MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 129 TABLE 99 ASIA PACIFIC: MEDICAL TUBING MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 129 TABLE 100 CHINA: MEDICAL TUBING MARKET, BY APPLICATION, 2021–2024 (KILOTON) 130 TABLE 101 CHINA: MEDICAL TUBING MARKET, BY APPLICATION, 2025–2030 (KILOTON) 131 TABLE 102 CHINA: MEDICAL TUBING MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 131 TABLE 103 CHINA: MEDICAL TUBING MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 131 TABLE 104 JAPAN: MEDICAL TUBING MARKET, BY APPLICATION, 2021–2024 (KILOTON) 132 TABLE 105 JAPAN: MEDICAL TUBING MARKET, BY APPLICATION, 2025–2030 (KILOTON) 132 TABLE 106 JAPAN: MEDICAL TUBING MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 132 TABLE 107 JAPAN: MEDICAL TUBING MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 133 TABLE 108 INDIA: MEDICAL TUBING MARKET, BY APPLICATION, 2021–2024 (KILOTON) 134 TABLE 109 INDIA: MEDICAL TUBING MARKET, BY APPLICATION, 2025–2030 (KILOTON) 134 TABLE 110 INDIA: MEDICAL TUBING MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 134 TABLE 111 INDIA: MEDICAL TUBING MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 134 TABLE 112 SOUTH KOREA: MEDICAL TUBING MARKET, BY APPLICATION, 2021–2024 (KILOTON) 135 TABLE 113 SOUTH KOREA: MEDICAL TUBING MARKET, BY APPLICATION, 2025–2030 (KILOTON) 135 TABLE 114 SOUTH KOREA: MEDICAL TUBING MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 136 TABLE 115 SOUTH KOREA: MEDICAL TUBING MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 136 TABLE 116 REST OF ASIA PACIFIC: MEDICAL TUBING MARKET, BY APPLICATION, 2021–2024 (KILOTON) 137 TABLE 117 REST OF ASIA PACIFIC: MEDICAL TUBING MARKET, BY APPLICATION, 2025–2030 (KILOTON) 137 TABLE 118 REST OF ASIA PACIFIC: MEDICAL TUBING MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 137 TABLE 119 REST OF ASIA PACIFIC: MEDICAL TUBING MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 138 TABLE 120 MIDDLE EAST & AFRICA: MEDICAL TUBING MARKET, BY COUNTRY, 2021–2024 (KILOTON) 138 TABLE 121 MIDDLE EAST & AFRICA: MEDICAL TUBING MARKET, BY COUNTRY, 2025–2030 (KILOTON) 139 TABLE 122 MIDDLE EAST & AFRICA: MEDICAL TUBING MARKET, BY COUNTRY, 2021–2024 (USD MILLION) 139 TABLE 123 MIDDLE EAST & AFRICA: MEDICAL TUBING MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 139 TABLE 124 MIDDLE EAST & AFRICA: MEDICAL TUBING MARKET, BY APPLICATION, 2021–2024 (KILOTON) 140 TABLE 125 MIDDLE EAST & AFRICA: MEDICAL TUBING MARKET, BY APPLICATION, 2025–2030 (KILOTON) 140 TABLE 126 MIDDLE EAST & AFRICA: MEDICAL TUBING MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 140 TABLE 127 MIDDLE EAST & AFRICA: MEDICAL TUBING MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 141 TABLE 128 SAUDI ARABIA: MEDICAL TUBING MARKET, BY APPLICATION, 2021–2024 (KILOTON) 142 TABLE 129 SAUDI ARABIA: MEDICAL TUBING MARKET, BY APPLICATION, 2025–2030 (KILOTON) 142 TABLE 130 SAUDI ARABIA: MEDICAL TUBING MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 142 TABLE 131 SAUDI ARABIA: MEDICAL TUBING MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 143 TABLE 132 UAE: MEDICAL TUBING MARKET, BY APPLICATION, 2021–2024 (KILOTON) 143 TABLE 133 UAE: MEDICAL TUBING MARKET, BY APPLICATION, 2025–2030 (KILOTON) 144 TABLE 134 UAE: MEDICAL TUBING MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 144 TABLE 135 UAE: MEDICAL TUBING MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 144 TABLE 136 SOUTH AFRICA: MEDICAL TUBING MARKET, BY APPLICATION, 2021–2024 (KILOTON) 145 TABLE 137 SOUTH AFRICA: MEDICAL TUBING MARKET, BY APPLICATION, 2025–2030 (KILOTON) 145 TABLE 138 SOUTH AFRICA: MEDICAL TUBING MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 145 TABLE 139 SOUTH AFRICA: MEDICAL TUBING MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 146 TABLE 140 EGYPT: MEDICAL TUBING MARKET, BY APPLICATION, 2021–2024 (KILOTON) 146 TABLE 141 EGYPT: MEDICAL TUBING MARKET, BY APPLICATION, 2025–2030 (KILOTON) 146 TABLE 142 EGYPT: MEDICAL TUBING MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 147 TABLE 143 EGYPT: MEDICAL TUBING MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 147 TABLE 144 REST OF MIDDLE EAST & AFRICA: MEDICAL TUBING MARKET, BY APPLICATION, 2021–2024 (KILOTON) 147 TABLE 145 REST OF MIDDLE EAST & AFRICA: MEDICAL TUBING MARKET, BY APPLICATION, 2025–2030 (KILOTON) 148 TABLE 146 REST OF MIDDLE EAST & AFRICA: MEDICAL TUBING MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 148 TABLE 147 REST OF MIDDLE EAST & AFRICA: MEDICAL TUBING MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 148 TABLE 148 SOUTH AMERICA: MEDICAL TUBING MARKET, BY COUNTRY, 2021–2024 (KILOTON) 149 TABLE 149 SOUTH AMERICA: MEDICAL TUBING MARKET, BY COUNTRY, 2025–2030 (KILOTON) 149 TABLE 150 SOUTH AMERICA: MEDICAL TUBING MARKET, BY COUNTRY, 2021–2024 (USD MILLION) 149 TABLE 151 SOUTH AMERICA: MEDICAL TUBING MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 150 TABLE 152 SOUTH AMERICA: MEDICAL TUBING MARKET, BY APPLICATION, 2021–2024 (KILOTON) 150 TABLE 153 SOUTH AMERICA: MEDICAL TUBING MARKET, BY APPLICATION, 2025–2030 (KILOTON) 150 TABLE 154 SOUTH AMERICA: MEDICAL TUBING MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 150 TABLE 155 SOUTH AMERICA: MEDICAL TUBING MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 151 TABLE 156 BRAZIL: MEDICAL TUBING MARKET, BY APPLICATION, 2021–2024 (KILOTON) 151 TABLE 157 BRAZIL: MEDICAL TUBING MARKET, BY APPLICATION, 2025–2030 (KILOTON) 151 TABLE 158 BRAZIL: MEDICAL TUBING MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 152 TABLE 159 BRAZIL: MEDICAL TUBING MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 152 TABLE 160 ARGENTINA: MEDICAL TUBING MARKET, BY APPLICATION, 2021–2024 (KILOTON) 153 TABLE 161 ARGENTINA: MEDICAL TUBING MARKET, BY APPLICATION, 2025–2030 (KILOTON) 153 TABLE 162 ARGENTINA: MEDICAL TUBING MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 153 TABLE 163 ARGENTINA: MEDICAL TUBING MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 153 TABLE 164 REST OF SOUTH AMERICA: MEDICAL TUBING MARKET, BY APPLICATION, 2021–2024 (KILOTON) 154 TABLE 165 REST OF SOUTH AMERICA: MEDICAL TUBING MARKET, BY APPLICATION, 2025–2030 (KILOTON) 154 TABLE 166 REST OF SOUTH AMERICA: MEDICAL TUBING MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 154 TABLE 167 REST OF SOUTH AMERICA: MEDICAL TUBING MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 155 TABLE 168 MEDICAL TUBING MARKET: OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS, 2020–2025 157 TABLE 169 MEDICAL TUBING MARKET: DEGREE OF COMPETITION, 2024 161 TABLE 170 MEDICAL TUBING MARKET: REGION FOOTPRINT 168 TABLE 171 MEDICAL TUBING MARKET: STRUCTURE FOOTPRINT 169 TABLE 172 MEDICAL TUBING MARKET: MATERIAL FOOTPRINT 170 TABLE 173 MEDICAL TUBING MARKET: APPLICATION FOOTPRINT 171 TABLE 174 MEDICAL TUBING MARKET: KEY STARTUPS/SMES 174 TABLE 175 MEDICAL TUBING MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES 175 TABLE 176 MEDICAL TUBING MARKET: PRODUCT LAUNCHES, JANUARY 2020–MARCH 2025 176 TABLE 177 MEDICAL TUBING MARKET: DEALS, JANUARY 2020–MARCH 2025 178 TABLE 178 MEDICAL TUBING MARKET: OTHER DEVELOPMENTS, JANUARY 2020–MARCH 2025 180 TABLE 179 SAINT-GOBAIN: COMPANY OVERVIEW 182 TABLE 180 SAINT-GOBAIN: PRODUCTS/SOLUTIONS/SERVICES OFFERED 183 TABLE 181 SAINT-GOBAIN: DEALS, JANUARY 2020–MARCH 2025 186 TABLE 182 FREUDENBERG MEDICAL: COMPANY OVERVIEW 187 TABLE 183 FREUDENBERG MEDICAL: PRODUCTS/SOLUTIONS/SERVICES OFFERED 188 TABLE 184 FREUDENBERG MEDICAL: PRODUCT LAUNCHES, JANUARY 2020–MARCH 2025 192 TABLE 185 FREUDENBERG MEDICAL: DEALS, JANUARY 2020–MARCH 2025 192 TABLE 186 FREUDENBERG MEDICAL: EXPANSIONS, JANUARY 2020–MARCH 2025 193 TABLE 187 THE LUBRIZOL CORPORATION: COMPANY OVERVIEW 195 TABLE 188 THE LUBRIZOL CORPORATION: PRODUCTS/SOLUTIONS/SERVICES OFFERED 196 TABLE 189 THE LUBRIZOL CORPORATION: DEALS, JANUARY 2020–MARCH 2025 198 TABLE 190 THE LUBRIZOL CORPORATION: EXPANSIONS, JANUARY 2020–MARCH 2025 198 TABLE 191 W. L. GORE & ASSOCIATES, INC.: COMPANY OVERVIEW 200 TABLE 192 W. L. GORE & ASSOCIATES, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 200 TABLE 193 NORDSON CORPORATION: COMPANY OVERVIEW 202 TABLE 194 NORDSON CORPORATION: PRODUCTS/SOLUTIONS/SERVICES OFFERED 203 TABLE 195 NORDSON CORPORATION: DEALS, JANUARY 2020–MARCH 2025 205 TABLE 196 TE CONNECTIVITY: COMPANY OVERVIEW 207 TABLE 197 TE CONNECTIVITY: PRODUCTS/SOLUTIONS/SERVICES OFFERED 208 TABLE 198 TE CONNECTIVITY: PRODUCT LAUNCHES, JANUARY 2020–MARCH 2025 209 TABLE 199 ELKEM ASA: COMPANY OVERVIEW 210 TABLE 200 ELKEM ASA: PRODUCTS/SOLUTIONS/SERVICES OFFERED 211 TABLE 201 ELKEM ASA: DEALS, JANUARY 2020–MARCH 2025 212 TABLE 202 ELKEM ASA: EXPANSIONS, JANUARY 2020–MARCH 2025 212 TABLE 203 TRELLEBORG AB: COMPANY OVERVIEW 213 TABLE 204 TRELLEBORG AB: PRODUCTS/SOLUTIONS/SERVICES OFFERED 214 TABLE 205 TRELLEBORG AB: DEALS, JANUARY 2020–MARCH 2025 216 TABLE 206 TRELLEBORG AB: OTHER DEVELOPMENTS, JANUARY 2020–MARCH 2025 216 TABLE 207 RAUMEDIC AG: COMPANY OVERVIEW 217 TABLE 208 RAUMEDIC AG: PRODUCTS/SOLUTIONS/SERVICES OFFERED 217 TABLE 209 RAUMEDIC AG: PRODUCT LAUNCHES, JANUARY 2020–MARCH 2025 219 TABLE 210 RAUMEDIC AG: DEALS, JANUARY 2020–MARCH 2025 219 TABLE 211 RAUMEDIC AG: EXPANSIONS, JANUARY 2020–MARCH 2025 220 TABLE 212 TEKNOR APEX: COMPANY OVERVIEW 221 TABLE 213 TEKNOR APEX: PRODUCTS/SOLUTIONS/SERVICES OFFERED 221 TABLE 214 TEKNOR APEX: PRODUCT LAUNCHES, JANUARY 2020–MARCH 2025 222 TABLE 215 TEKNOR APEX: DEALS, JANUARY 2020–MARCH 2025 222 TABLE 216 SPECTRUM PLASTICS GROUP: COMPANY OVERVIEW 224 TABLE 217 SPECTRUM PLASTICS GROUP: PRODUCTS/SOLUTIONS/SERVICES OFFERED 224 TABLE 218 SPECTRUM PLASTICS GROUP: DEALS, JANUARY 2020–MARCH 2025 226 TABLE 219 SPECTRUM PLASTICS GROUP: EXPANSIONS, JANUARY 2020–MARCH 2025 226 TABLE 220 ZEUS COMPANY LLC: COMPANY OVERVIEW 228 TABLE 221 ZEUS COMPANY LLC: PRODUCTS/SOLUTIONS/SERVICES OFFERED 228 TABLE 222 ZEUS COMPANY LLC: PRODUCT LAUNCHES, JANUARY 2020–MARCH 2025 230 TABLE 223 ZEUS COMPANY LLC: EXPANSIONS, JANUARY 2020–MARCH 2025 230 TABLE 224 ATAG SPA: COMPANY OVERVIEW 231 TABLE 225 DAVIS STANDARD: COMPANY OVERVIEW 232 TABLE 226 FBK MEDICAL TUBING: COMPANY OVERVIEW 233 TABLE 227 PROTERIAL CABLE AMERICA, INC.: COMPANY OVERVIEW 234 TABLE 228 ICO RALLY: COMPANY OVERVIEW 235 TABLE 229 ICU MEDICAL, INC.: COMPANY OVERVIEW 236 TABLE 230 KRATON CORPORATION: COMPANY OVERVIEW 237 TABLE 231 MICROLUMEN INC.: COMPANY OVERVIEW 238 TABLE 232 MDC INDUSTRIES: COMPANY OVERVIEW 239 TABLE 233 NEWAGE INDUSTRIES: COMPANY OVERVIEW 240 TABLE 234 OPTINOVA: COMPANY OVERVIEW 241 TABLE 235 PARKER HANNIFIN CORP.: COMPANY OVERVIEW 242 TABLE 236 TEEL PLASTICS: COMPANY OVERVIEW 243 TABLE 237 VESTA INC.: COMPANY OVERVIEW 244 TABLE 238 SMOOTH-BOR PLASTICS: COMPANY OVERVIEW 245 _ FIGURE 1 MEDICAL TUBING MARKET SEGMENTATION AND REGIONAL SCOPE 26 FIGURE 2 MEDICAL TUBING MARKET: RESEARCH DESIGN 29 FIGURE 3 MEDICAL TUBING MARKET: BOTTOM-UP APPROACH 33 FIGURE 4 MEDICAL TUBING MARKET: TOP-DOWN APPROACH 33 FIGURE 5 MARKET SIZE ESTIMATION: MEDICAL TUBING MARKET, TOP-DOWN APPROACH 34 FIGURE 6 DEMAND-SIDE FORECAST PROJECTIONS 34 FIGURE 7 MEDICAL TUBING MARKET: DATA TRIANGULATION 35 FIGURE 8 RUBBERS TO BE FASTEST-GROWING MATERIAL SEGMENT IN MEDICAL TUBING MARKET DURING FORECAST PERIOD 38 FIGURE 9 CATHETERS & CANNULAS APPLICATION TO LEAD OVERALL MARKET DURING FORECAST PERIOD 38 FIGURE 10 ASIA PACIFIC TO BE FASTEST-GROWING MARKET DURING FORECAST PERIOD 39 FIGURE 11 ASIA PACIFIC TO REGISTER HIGHEST GROWTH IN MEDICAL TUBING MARKET DURING FORECAST PERIOD 40 FIGURE 12 SPECIALTY POLYMERS SEGMENT TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD 40 FIGURE 13 BULK DISPOSABLE TUBING SEGMENT TO LEAD OVERALL MARKET BY 2030 41 FIGURE 14 ASIA PACIFIC TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD 41 FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN MEDICAL TUBING MARKET 42 FIGURE 16 MEDICAL TUBING MARKET: PORTER’S FIVE FORCES ANALYSIS 51 FIGURE 17 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE APPLICATIONS 53 FIGURE 18 KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS 54 FIGURE 19 MEDICAL TUBING MARKET: VALUE CHAIN ANALYSIS 58 FIGURE 20 IMPORT DATA FOR HS CODE 3917-COMPLIANT PRODUCTS, BY KEY COUNTRY, 2020–2024 (USD MILLION) 64 FIGURE 21 EXPORT DATA RELATED TO HS CODE 3917-COMPLIANT PRODUCTS, BY KEY COUNTRY, 2020–2024 (USD MILLION) 65 FIGURE 22 MEDICAL TUBING MARKET: ECOSYSTEM ANALYSIS 66 FIGURE 23 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS IN MEDICAL TUBING MARKET 68 FIGURE 24 MEDICAL TUBING MARKET: GRANTED PATENTS, 2015–2024 73 FIGURE 25 NUMBER OF PATENTS PER YEAR, 2015–2024 73 FIGURE 26 LEGAL STATUS OF PATENTS, 2015–2024 74 FIGURE 27 TOP JURISDICTION, BY DOCUMENT, 2015–2024 74 FIGURE 28 TOP 10 PATENT APPLICANTS, 2015–2024 75 FIGURE 29 AVERAGE SELLING PRICE, BY REGION, 2021–2024 (USD/KG) 76 FIGURE 30 AVERAGE SELLING PRICE FOR TOP THREE APPLICATIONS, BY KEY PLAYER, 2024 (USD/KG) 77 FIGURE 31 AVERAGE SELLING PRICE TREND, BY MATERIAL, 2021–2024 (USD/KG) 77 FIGURE 32 MEDICAL TUBING, INVESTMENT AND FUNDING SCENARIO, 2020–2024 78 FIGURE 33 CATHETERS & CANNULAS TO BE LARGEST APPLICATION OF MEDICAL TUBING MARKET DURING FORECAST PERIOD 80 FIGURE 34 RUBBERS SEGMENT TO DOMINATE MEDICAL TUBING MARKET DURING FORECAST PERIOD 88 FIGURE 35 MULTI-LUMEN SEGMENT TO DOMINATE MEDICAL TUBING MARKET DURING FORECAST PERIOD 96 FIGURE 36 INDIA TO BE FASTEST-GROWING MARKET FOR MEDICAL TUBING DURING FORECAST PERIOD 102 FIGURE 37 NORTH AMERICA: MEDICAL TUBING MARKET SNAPSHOT 104 FIGURE 38 EUROPE: MEDICAL TUBING MARKET SNAPSHOT 112 FIGURE 39 ASIA PACIFIC: MEDICAL TUBING MARKET SNAPSHOT 127 FIGURE 40 MEDICAL TUBING MARKET: REVENUE ANALYSIS OF KEY COMPANIES, 2021–2023 159 FIGURE 41 MEDICAL TUBING MARKET SHARE ANALYSIS, 2024 160 FIGURE 42 MEDICAL TUBING MARKET: COMPANY VALUATION OF LEADING COMPANIES, 2024 163 FIGURE 43 MEDICAL TUBING MARKET: FINANCIAL METRICS OF LEADING COMPANIES, 2024 163 FIGURE 44 BRAND COMPARISON 164 FIGURE 45 COMPANY EVALUATION MATRIX, KEY PLAYERS, 2024 166 FIGURE 46 MEDICAL TUBING MARKET: COMPANY FOOTPRINT 167 FIGURE 47 MEDICAL TUBING MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 173 FIGURE 48 SAINT-GOBAIN: COMPANY SNAPSHOT 183 FIGURE 49 FREUDENBERG GROUP: COMPANY SNAPSHOT 188 FIGURE 50 NORDSON CORPORATION: COMPANY SNAPSHOT 203 FIGURE 51 TE CONNECTIVITY: COMPANY SNAPSHOT 208 FIGURE 52 ELKEM ASA: COMPANY SNAPSHOT 211 FIGURE 53 TRELLEBORG AB: COMPANY SNAPSHOT 214

Single User Licence	$4,950 USD
Multi User Licence	$6,650 USD
Corporate User Licence	$8,150 USD
Global User Licence	$10,000 USD

Medical Tubing Market by Material (Plastics, Rubbers, Specialty Polymers), Application (Bulk Disposable Tubing, Catheters & Cannulas, Drug Delivery Systems), Structure (Single-Lumen, Multi-Lumen, Co-Extruded, Tapered or Bump, Braided) - Global Forecast to 2030

授權報價

報告摘要

同分類最新報告（化學與材料）